Browsing by Subject "ALDH1A3"
Now showing items 1-2 of 2
-
EVALUATING INHIBITION OF DNA METHYLATION AND ALDH1A3 AS BREAST CANCER THERAPIES
(2020-09-01)Breast cancer is the most common form of cancer among Canadian women. Patients with triple-negative breast cancer (TNBC) have poor prognoses, with inherently more aggressive disease and limited treatment options. New ... -
TRIPLE-NEGATIVE BREAST CANCER STEM CELL MARKER ALDH1A3 REGULATES THE PLASMINOGEN PATHWAY TO PROMOTE INVASION AND METASTASIS
(2023-09-28)Aldehyde dehydrogenase 1A3 (ALDH1A3) is a cancer stem cell marker that also increases tumour growth, promotes metastasis, and contributes to chemoresistance. Metastasis of triple-negative breast cancer (TNBC) has been ...